• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Does Elective Induction of Labor at 39 Weeks Gestation Lead to Improved Maternal and Newborn Outcomes?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE: 

  • Previous RCTs indicate that nonmedically indicated induction ≥39 weeks gestation compared with expectant management  
    • Does not negatively impact outcomes and may even provide benefit, including reduced cesarean section rates  
    • Has generated positive guidance regarding acceptability of this practice in very defined circumstances (see ‘Related ObG Topics’ below)
  • Unclear if results applicable to the broader US pregnant population 
  • Souter et al. (AJOG, 2019) compared induction at ≥39 weeks gestation vs non-electively induced pregnancies

METHODS: 

  • Retrospective cohort study 
    • Chart extraction: 21 US Hospitals
    • Singleton | Cephalic | Hospital birth at 39w0d – 42w6d  
  • Exclusion criteria  
    • Previous cesarean birth |Missing key delivery data | Stillbirth |Cesarean birth without trial of labor | Fetal anomaly | Maternal complications including GDM, prepregnancy diabetes and hypertension
  • Primary outcome: Cesarean birth 
    • Compared rate of cesarean birth for elective inductions at 39 weeks and 40 weeks vs on-going pregnancies in the same gestational week 
  • Secondary maternal outcomes included  
    • Operative vaginal birth | Shoulder dystocia | 3rd- or 4th-degree perineal laceration | Pregnancy-related hypertension | PPH  
  • Secondary newborn outcomes included  
    • Macrosomia | 5-minute Apgar <7 | Resuscitation at delivery | Intubation | Respiratory complications | NICU admission 
  • Length of hospital stay also assessed  
  • Statistical Analysis 
    • Logistic regression – adjusted for maternal age and body mass index, parity, gestational age  

RESULTS: 

  • 55,694 births 
    • Elective inductions (≥39+0 weeks): 4,002  
    • Not electively induced (39 – 42 weeks):  51,692  

Nulliparous women undergoing elective induction at 39 weeks  

  • Decreased cesarean birth rate  
    • Induction: 14.7%  
    • Expectant management: 23.2%  
    • Adjusted odds ratio (OR) 0.61 (95% CI, 0.41-0.89)
  • Increased rate of operative vaginal birth 
    • Induction: 18.5%  
    • Expectant management: 10.8%  
    • aOR 1.8 (95% CI, 1.28–2.54) 
  • Decreased risk of pregnancy-related hypertension  
    • Induction: 2.2%  
    • Expectant management: 7.3% 
    • aOR 0.28 (95% CI, 0.11–0.68) 

Multiparous women undergoing elective induction at 39 weeks 

  • Decreased risk of pregnancy-related hypertension  
    • Induction: 0.9%  
    • Expectant management: 3.5% 
    • aOR 0.24 (95% CI, 0.15–0.38) 

Newborn outcomes 

  • No significant increase with induction  

Length of hospital stay for women undergoing elective induction at 39 weeks  

  • Increased time from admission to delivery for both nulliparous (1.3 hours) and multiparous women (3.4 hours) 

CONCLUSION: 

  • Elective induction of labor at 39 weeks was associated with reduced cesarean rates in nulliparous women and decreased risk of pregnancy related hypertension in both nulliparous and multiparous women without increasing risk of adverse newborn outcomes  
  • The authors state 

Additional assessment of the impact and outcomes of this intervention in a range of settings and the economic impact are imperative before elective induction of labor becomes offered routinely. 

Learn more – Primary Sources: 

Maternal and newborn outcomes with elective induction of labor at term 

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

Learn More »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

The ARRIVE Trial and Professional Guidance: Elective 39 Week Induction to Reduce the Risk of Cesarean Section
Does Elective Induction Lower Risk for Adverse Obstetrical Outcomes in the Setting of Obesity
Is Elective Induction Linked to Lower Risk of C-section?
Practical info on evidence based medicine for your women's healthcare practice
Labor induction and an unripe cervix: does it result in more C-sections?

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site